BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22474248)

  • 1. C/EBPα and DEK coordinately regulate myeloid differentiation.
    Koleva RI; Ficarro SB; Radomska HS; Carrasco-Alfonso MJ; Alberta JA; Webber JT; Luckey CJ; Marcucci G; Tenen DG; Marto JA
    Blood; 2012 May; 119(21):4878-88. PubMed ID: 22474248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
    Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B
    J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma proliferation and chemoresistance controlled by the DEK oncogene.
    Khodadoust MS; Verhaegen M; Kappes F; Riveiro-Falkenbach E; Cigudosa JC; Kim DS; Chinnaiyan AM; Markovitz DM; Soengas MS
    Cancer Res; 2009 Aug; 69(16):6405-13. PubMed ID: 19679545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
    Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
    Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: role of DEK in stem/progenitor cell biology.
    Broxmeyer HE; Mor-Vaknin N; Kappes F; Legendre M; Saha AK; Ou X; O'Leary H; Capitano M; Cooper S; Markovitz DM
    Stem Cells; 2013 Aug; 31(8):1447-53. PubMed ID: 23733396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
    Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
    J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia.
    Wilcher KE; Page ERH; Privette Vinnedge LM
    Exp Hematol; 2023 Jul; 123():18-27. PubMed ID: 37172756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.
    Alberich-Jordà M; Wouters B; Balastik M; Shapiro-Koss C; Zhang H; Di Ruscio A; Radomska HS; Ebralidze AK; Amabile G; Ye M; Zhang J; Lowers I; Avellino R; Melnick A; Figueroa ME; Valk PJ; Delwel R; Tenen DG
    J Clin Invest; 2012 Dec; 122(12):4490-504. PubMed ID: 23160200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human DEK oncogene regulates DNA damage response signaling and repair.
    Kavanaugh GM; Wise-Draper TM; Morreale RJ; Morrison MA; Gole B; Schwemberger S; Tichy ED; Lu L; Babcock GF; Wells JM; Drissi R; Bissler JJ; Stambrook PJ; Andreassen PR; Wiesmüller L; Wells SI
    Nucleic Acids Res; 2011 Sep; 39(17):7465-76. PubMed ID: 21653549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.
    Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
    Med Oncol; 2021 May; 38(6):69. PubMed ID: 34002296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
    Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
    Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for intracellular and extracellular DEK in regulating hematopoiesis.
    Capitano ML; Broxmeyer HE
    Curr Opin Hematol; 2017 Jul; 24(4):300-306. PubMed ID: 28306668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
    Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
    Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.
    Chen Z; Huo D; Li L; Liu Z; Li Z; Xu S; Huang Y; Wu W; Zhou C; Liu Y; Kuang M; Wu F; Li H; Qian P; Song G; Wu X; Chen J; Hou Y
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33755722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
    Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
    Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
    Wurm AA; Zjablovskaja P; Kardosova M; Gerloff D; Bräuer-Hartmann D; Katzerke C; Hartmann JU; Benoukraf T; Fricke S; Hilger N; Müller AM; Bill M; Schwind S; Tenen DG; Niederwieser D; Alberich-Jorda M; Behre G
    Nat Commun; 2017 Jun; 8(1):46. PubMed ID: 28663557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway.
    Numata A; Shimoda K; Kamezaki K; Haro T; Kakumitsu H; Shide K; Kato K; Miyamoto T; Yamashita Y; Oshima Y; Nakajima H; Iwama A; Aoki K; Takase K; Gondo H; Mano H; Harada M
    J Biol Chem; 2005 Apr; 280(13):12621-9. PubMed ID: 15664994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBPalpha S248A mutation reduces granulocytic differentiation in human leukemic K562 cells.
    Singh SM; Trivedi AK; Behre G
    Biochem Biophys Res Commun; 2008 May; 369(2):692-4. PubMed ID: 18302931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
    Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
    Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.